Annals of Epidemiology 1992: Vol 2 Index

15 Pages·1992·3.8 MB·English

Author Index
Aaby P. Patterns of exposure and severity of Buring JE, Hennekens CH. Ethics and
measles infection: Copenhagen 1915-1925, epidemiology (editorial), 761
257-262 Buring JE. see Buffler PA
Ances IG. see Scholl TO Bushhouse SA. see Sprafka JM
Anderson K. see Castelli WP
Anderson KM. see O’Leary DH
Califf RM, Pieper KS, Harlan WR, Lee KL.
Anderson M. see Lamm SH
Serum cholesterol in patients undergoing cardiac
Andres R. see Sorkin JD
catheterization for suspected coronary artery
Ansari GAS. see Dayal HH
disease: diagnostic and prognostic implications,
Applegate WB. see Whelton PK
137-145
Arky RA. see Manson JE
Carstensen JM. see Eklund GA
Aronson M. see Frishman WH
Castelli WP, Anderson K, Wilson PWF, Levy D.
Lipids and risk of coronary heart disease: the
Baldwin HL. see Sorkin JD
Framingham Study, 23-28
Baptiste MS. see Nasca PC
Chambless LE, McMahon R, Wu K, Folsom A,
Baranowski T. see Dayal HH
Finch A, Shen Y-L. Short-term intraindividual
Barnes R. see Wu KK
variability in hemostasis factors: the ARIC
Barrett-Connor E
Study, 723-733
Hypercholesterolemia predicts early death from
Cohen BH. see Cotch MF
coronary heart disease in elderly men but not
Colditz GA
women: the Rancho Bernardo Study, 77—83
see Hunter D]
see Khaw K-T
see Manson JE
see Manolio TA
Collen D. see Juhan-Vague |
Bauer KA. see Roberts HR
Colsher PL. see Wallace RB
Beaty TH. see Cotch MF
Conlan MG
Beaumont JJ. see Kass PH
see Folsom AR
Belanger AJ. see Kannel WB
see Wu KK
Ben-Zeev D. see Frishman WH
Cooper C. see Jacobsen SJ
Benfante R
Cooper RS, Ford E. Comparability of risk factors
Reed D, Frank J. Do coronary heart disease risk
for coronary heart disease among blacks and
factors measured in the elderly have the same
whites in the NHANES-I Epidemiologic
predictive roles as in the middle aged:
Follow-up Study, 637-645
comparisons of relative and attributable risks,
Cotch MF, Beaty TH, Mufioz A, Cohen BH.
273-282
Estimating familial aggregation while adjusting
see Reed D
for covariates: application to pulmonary function
Berkowitz GS, Marcus M. Adolescence and
data from black and white sibships, 317-324
pregnancy outcome (editorial) 755-757
Cutler J. see Whelton PK
Borhani NO. see Whelton PK
Borth W. see Harpel PC
Bovill EG. see Tracy RP D’Agostino RB. see Kannel WB
Brinton LA, Swanson CA. Height and weight at Daly PB. see Smith PW
various ages and risk of breast cancer, 597—609 Davis CE
Brodwick M. see Dayal HH see Folsom AR
Buffler PA, Buring JE. Women and health see Wu KK
(editorial) 759-760 Dawson S. see Humphries SE
© 1992 Elsevier Science Publishing Co., Inc. 1047-2797/92/$03.50
858 AUTHOR INDEX AEP Vol. 2, No. 6
November 1992: 857—862
Dayal HH, Brodwick M, Morris R, Baranowski T, Ford CE. see Tyroler HA
Trieff N, Harrison JA, Lisse JR, Ansari GAS. A Ford E. see Cooper RS
community-based epidemiologic study of health Frank J. see Benfante R
sequelae of exposure to hydrofluoric acid, Freedman DS. see Flanders WD
213-230 French R. see Sprafka JM
DeMartino R. see Nasca PC Fried LP. see Tracy RP
Derman MP. see Frishman WH Frishman WH, Ooi WL, Derman MP, Eder HA,
DerSimonian R. see Flanders WD Gidez LI, Ben-Zeev D, Zimetbaum P, Heiman
Dinale A. see Wilson A M, Aronson M. Serum lipids and lipoproteins in
Dodds L. see Marrett LD advanced age: intraindividual changes, 43—50
Doll R. Is cadmium a human carcinogen?
(editorial), 335-337
Galai N. see Simchen E
Donahue RP. see Orchard TJ
Galbraith MA. see Vermund SH
Drash AL. see Orchard TJ
Gazes PC. see Keil JE
Dyer AR, Stamler J, Shekelle RB. Serum
Genigeorgis C. see Kass PH
cholesterol and mortality from coronary heart
Gidez LI. see Frishman WH
disease in young, middle-aged, and older men
Gillman MW, Lannon CM. (letter), 766—767
and women from three Chicago epidemiologic
Gillum R. see Harris T
studies, 51—57
Goetz FC. see Sprafka JM
Goldberg J
Eberlein KA. see Whelton PK Eisen SA, True WR, Henderson WG. Health
Ebner SC. see Vermund SH effects of military service: lessons learned from
Eder HA. see Frishman WH the Vietnam experience, 841-853
Eisen SA. see Goldberg J see Jacobsen SJ
Eklund GA, Carstensen JM, Lindberg G, Gullberg Green FR. see Humphries SE
B, Rastam L, Térnberg SA. Serum levels of Greenland S
cholesterol and ischemic heart disease mortality: (letter), 769-770
the Varmland Study, 121-128 Likelihood-ratio testing as a diagnostic method
Eriksson H. see Welin L for small-sample regressions, 311-316
Evans JC. see O’Leary DH Greenwald P. (letter), 343-344
Exner T. see Wilson A Gullberg B. see Eklund GA
Farver TB. see Kass PH Haffner SM. see Mitchell BD
Feldman JJ. see Harris T Hajjar KA. Assembly of plasmin-generating
Field NA. see Nasca PC proteins on the surface of human endothelial
Finch A. see Chambless LE cells, 419-426
FitzGerald GA, Shipp E. Antiplatelet and Hames CG. see White AD
anticoagulant drugs in coronary vascular disease, Hamill S. see Whelton PK
529-542 Hamsten A. see Humphries SE
Flanders WD, DerSimonian R, Freedman DS. Harlan WR
Interpretation of linear models that include Introduction, 1—3
transformations or interaction terms, 735—744 see Califf RM
Fleg JL. see Sorkin JD see Manolio TA
Fletcher RH. Clinical medicine meets modern Harpel PC, Borth W. Identification of mechanisms
epidemiology—and both profit (commentary), that may modulate the role of lipoprotein(a) in
325-333 thrombosis and atherogenesis, 413—417
Folsom A. see Chambless LE Harris T, Kleinman JC, Makuc DM, Gillum R,
Folsom AR Feldman JJ. Is weight loss a modifier of the
Conlan MG, Davis CE, Wu KK. Relations cholesterol—heart disease relationship in older
between hemostasis variables and persons? Data from the NHANES |
cardiovascular risk factors in middle-aged Epidemiologic Follow-up Study, 35—41
adults, 481-494 Harrison JA. see Dayal HH
see Potter JD Haverkate F, Thompson SG, van de Loo JC. The
see Wu KK relationship between hemostatic tests and
AEP Vol. 2, No. 6 AUTHOR INDEX 859
November 1992: 857-862
cardiovascular risk factors in patients with Kannel WB
angina pectoris: European Concerted Action on D'Agostino RB, Belanger AJ. Update on
Thrombosis and Disabilities (ECAT) Angina fibrinogen as a cardiovascular risk factor,
Pectoris Group, 521-524 457-466
Hazuda HP. see Mitchell BD Vokonas PS. Demographics of the prevalence,
Hebert PR. see Whelton PK incidence, and management of coronary heart
Hediger ML. see Scholl TO disease in the elderly and in women, 5—14
Heiman M. see Frishman WH Kaplan GA. Maintenance of functioning in the
Heiss G elderly, 823—834
see Tracy RP Kaslow RA. see Vermund SH
see Wu KK Kass PH, Farver TB, Beaumont JJ, Genigeorgis C,
Heller R. see Wilson A Stevens F. Disease determinants of sporadic
Henderson WG. see Goldberg J salmonellosis in four northern California
Hennekens CH counties: a case-control study of older children
see Buring JE and adults, 683—696
see Manson JE Katsouyanni K. see Petridou E
see Roberts HR Keil JE, Sutherland SE, Knapp RG, Gazes PC.
Henney A. see Humphries SE Serum cholesterol—risk factor for coronary
Higgins M disease mortality in younger and older blacks
Introduction, 351—352 and whites: the Charleston Heart
Keller JB. Cholesterol, coronary heart disease, Study, 1960-1988, 93-99
and total mortality in middle-aged and elderly Kelleher CH. see Humphries SE
men and women in Tecumseh, 69—76 Keller JB. see Higgens M
see Roberts HR Keough ME. see Whelton PK
Hilditch S. see Marrett LD Khaw K-T, Barrett-Connor E. Lower endogenous
Hinman AR, Orenstein WA, Mortimer EA, Jr. androgens predict central adiposity in men,
When, where, and how do immunizations fail?, 675-682
805-812 Kim MY. (letter), 344-345
Hjermann |. The influence of dietary change on Kiss JE. see Meilahn EN
hemostatic risk variables, 525-527 Klag MJ. see Whelton PK
Holdaway I. see Scragg R Klein BEK. see Klein R
Hollis J. see Whelton PK Klein R, Moss SE, Klein BEK. Change in
Huang J. see Scholl TO glycemia in a four-year interval in younger-onset
Humphries SE, Green FR, Temple A, Dawson S, insulin-dependent diabetes, 283-294
Henney A, Kelleher CH, Wilkes H, Meade Kleinman JC. see Harris T
TW, Wiman B, Hamsten A. Genetic factors Knapp RG. see Keil JE
determining thrombosis and fibrinolysis, Kosinski AJ. see Kronmal RA
371-385 Koutts J. see Wilson A
Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Kraus JF. see Peek C
Willett WC, Speizer FE. Diet and risk of basal Kreiger N. see Marrett LD
cell carcinoma of the skin in a prospective Kronmal RA, Kosinski AS, Mock MB. The
cohort of women, 231-239 relationship between cholesterol level and
myocardial infarction or mortality risk in
Israeli A. see Simchen E patients with coronary artery disease: a report
from the Coronary Artery Surgery Study
Jackson R. see Scragg R (CASS) registry, 129-136
Jacobsen SJ, Goldberg J, Cooper C, Lockwood Kuller LH. see Meilahn EN
SA. The association between water fluoridation
and hip fracture among white women and men Lamm SH, Parkinson M, Anderson M, Taylor W.
aged 65 years and older: a national ecologic Determinants of lung cancer risk among
study, 617-626 cadmium-exposed workers, 195-211
Johnson FE. see Scholl TO Lannon CM. see Gillman MW
Juhan-Vague I, Collen D. On the role of Larsson B. see Welin L
coagulation and fibrinolysis in atherosclerosis, Lee KL. see Califf RM
427-438 Lee MH. see Tracy RP
860 AUTHOR INDEX AEP Vol. 2, No. 6
November 1992: 857—862
Leeder S. see Wilson A Morris RD, Rimm AA. Long-term weight
Lemen R. see Stayner L. fluctuation and non—insulin-dependent diabetes
Levy D. see Castelli WP mellitus in white women, 657-664
Lim T. see Scragg R Mortimer EA, Jr. see Hinman AR
Lindberg G. see Eklund GA Moss SE. see Klein R
Lisse JR. see Dayal HH Muller DC. see Sorkin JD
Lockwood SA. see Jacobsen S] Muller JE, Tofler GH. Triggering and hourly
Lowenfels AB, Wynn PS. One less for the road: variation of onset of arterial thrombosis,
international trends in alcohol consumption and 393-405
vehicular fatalities, 249-256 Mufioz A. see Cotch MF
Makuc DM. see Harris T
Nagey DA. see Yu SM
Mann KG. Potential analytes for the diagnosis of
Nasca PC, Baptiste MS, Field NA, Metzger BB,
thrombosis: an overview, 365-370
DeMartino R. An epidemiologic case-control
Mann KG. see Roberts HR
study of breast cancer and exposure to hair dyes,
Manolio TA, Pearson TA, Wenger NK,
577-586
Barrett-Connor E, Payne GH, Harlan WR.
Nathan DM. see Manson JE
Cholesterol and heart disease in older persons
and women: review of an NHLBI workshop,
Oberman A. see Whelton PK
161-176
O’Leary DH, Anderson KM, Wolf PA, Evans JC,
Manson JE, Rimm EB, Colditz GA, Willett WC,
Poehlman HW. Cholesterol and carotid
Nathan DM, Arky RA, Rosner B, Hennekens
atherosclerosis in older persons: the Framingham
CH, Speizer FE, Stampfer MJ. A prospective
Study, 147-153
study of postmenopausal estrogen therapy and
Ooi WL. see Frishman WH
subsequent incidence of non—insulin-dependent
Orchard TJ, Drash AL, Donahue RP, Stuhldreher
diabetes mellitus, 665-673
WL. (letter), 763-765
Marcus M. see Berkowitz GS
Orenstein WA. see Hinman AR
Marrett LD, Kreiger N, Dodds L, Hilditch S. The
effect on response rates of offering a small
incentive with a mailed questionnaire, 745-753 Pangiotopoulou K. see Petridou E
Martinez AM. see Sprafka JM Parkinson M. see Lamm SH
Matthews KA. see Meilahn EN Patterson JK. see Mitchell BD
McGovern PG. see Potter JD Payne GH. see Manolio TA
McMahon R. see Chambless LE Pearson TA. see Manolio TA
Meade TW Peek C, Kraus JF. International findings on
Thrombosis and cardiovascular disease, 353-364 alcohol consumption and vehicle crash fatalities:
see Humphries SE the role of the ecologic study (editorial),
see Roberts HR 339-341
Meilahn EN, Kuller LH, Matthews KA, Kiss JE. Petridou E, Katsouyanni K, Spanos E, Skalkidis Y,
Hemostatic factors according to menopausal Panagiotopoulou K, Trichopoulos D. Pregnancy
status and use of hormone replacement therapy, estrogens in relation to coffee and alcohol
445-455 intake, 241- 247
Menotti A. The relationship of total serum Pieper KS. see Califf RM
cholesterol to coronary heart disease in older Poehlman HW. see O’Leary DH
men: the Italian rural areas of the Seven Polak JF. see Tracy RP
Countries Study, 107-111 Potter JD, Sellers TA, Folsom AR, McGovern
Metzger BB. see Nasca PC PG. Alcohol, beer, and lung cancer in
Miller GJ. Environmental influences on hemostasis postmenopausal women: the lowa Women’s
and thrombosis: diet and smoking, 387-391 Health Study, 587—595
Mitchell BD, Haffner SM, Hazuda HP, Patterson Psaty BM. see Tracy RP
JK, Stern MP. Diabetes and coronary heart
disease risk in Mexican Americans, 101—106 Rapaport E. Thrombolytic therapy for myocardial
Mock MB. see Kronmal RA ischemia and infarction, 543—548
Morris R. see Dayal HH Rastam L. see Eklund GA
AEP Vol. 2, No. 6 AUTHOR INDEX 861
November 1992: 857-862
Reed D Sorkin JD, Andres R, Muller DC, Baldwin HL,
Benfante R. Lipid and lipoprotein predictors of Fleg JL. Cholesterol as a risk factor for coronary
coronary heart disease in elderly men in the heart disease in elderly men: the Baltimore
Honolulu Heart Program, 29-34 Longitudinal Study of Aging, 59-67
see Benfante R Spanos E. see Petridou E
Rimm AA. see Morris RD Speizer FE
Rimm EB. see Manson JE see Hunter D]
Risch HA. (letter), 767—769 see Manson JE
Roberts HR, Bauer KA, Mann KG, Hennekens Sprafka JM, Xue S, Bushhouse SA, French LR,
CH, Meade TW, Willerson JT, Higgins M. Martinez AM, Goetz FC. Cardiovascular disease
Overview and research opportunities, 553-555 risk factors and glucose tolerance: the Wadena
Roccaforte JS. see Smith PW City Health Study, 647-656
Rosner B Stamler J. see Dyer AR
see Hunter D] Stampfer M]
see Manson JE see Hunter D]
see Manson JE
Savage PJ. see Tracy RP Stayner L, Smith R, Thun M, Schnorr T, Lemen
Scanu AM. Lipoprotein(a): link between structure R. A dose-response analysis and quantitative
and pathology, 407—412 assessment of lung cancer risk and occupational
Schieken RM. (letter), 765 cadmium exposure, 177—194
Schnorr T. see Stayner L. Stern MP. see Mitchell BD
Scholl TO, Hediger ML, Huang J, Johnson FE, Stevens F. see Kass PH
Smith W, Ances IG. Young maternal age and Stuhldreher WL. see Orchard T]
parity: influences on pregnancy outcome, Sutherland SE. see Keil JE
565-575 Svardsudd K. see Welin L
Schwartz J, Weiss ST. Caffeine intake and asthma Swanson CA. see Brinton LA
symptoms, 627-635
Taylor W. see Lamm SH
Scragg R, Holdaway I, Jackson R, Lim T. Plasma
Temple A. see Humphries SE
25-hydroxyvitamin D3 and its relation to
Thompson SG. see Haverkate F
physical activity and other heart disease risk
Thun M. see Stayner L.
factors in the general population, 697—703
Tibblin G. see Welin L
Seidell JC. see van Leer EM
Tofler GH see Muller JE
Seigel DG. (letter), 343
Térnberg SA. see Eklund GA
Sellers TA. see Potter JD
Tracy RP, Bovill EG, Fried LP, Heiss G, Lee MH,
Sharrett AR. The Atherosclerosis Risk in
Polak JF, Psaty BM, Savage PJ. The distribution
Communities (ARIC) Study: introduction and
of coagulation factors VII and VIII and
objectives of the hemostasis component,
fibrinogen in adults over 65 years: results from
467-469
the Cardiovascular Health Study, 509-519
Shekelle RB. see Dyer AR
Trichopoulos D. see Petridou E
Shen Y-L. see Chambless LE
Trieff N. see Dayal HH
Sheon AR. see Vermund SH
True WR. see Goldberg J
Shipp E. see FitzGerald GA
Tyroler HA
Simchen E, Wax Y, Galai N, Israeli A.
Ford CE. Serum cholesterol and coronary heart
Differential effect of risk factors on early and
disease risk in female and older hypertensives:
late wound infections in patients undergoing
the experience under usual community care in
herniorrhaphies, 263-272
the Hypertension Detection and Follow-up
Skalkidis Y. see Petridou E
Program, 155—160
Smith P. Long-term anticoagulant treatment after
see White AD
acute myocardial infarction: The Warfarin
Re-Infarction Study, 549-552 van de Loo JC. see Haverkate F
Smith PW, Roccaforte JS, Daly PB. Infection and van Leer EM, van Noord PAH, Seidell JC.
immune response in the elderly, 813-822 Components of adult height and height loss:
Smith R. see Stayner L secular trend and effects of aging in women in
Smith W. see Scholl TO the DOM project, 611—615
862 AUTHOR INDEX AEP Vol. 2, No. 6
November 1992: 857-862
van Noord PAH. see van Leer EM white men and women aged 65 and older in the
Vermund SH, Galbraith MA, Ebner SC, Sheon Evans County Heart Study, 85-91
AR, Kaslow RA. Human immunodeficiency Wilhelmsem L. see Welin L
virus/acquired immunodeficiency syndrome in Wilkes H. see Humphries SE
pregnant women, 773-803 Willerson JT. see Roberts HR
Vokonas PS. see Kannel WB Willett WC
see Hunter DJ
see Manson JE
Wallace RB Wilson A, Leeder S, Koutts J, Heller R, Exner T,
Colsher PL. Blood lipid distributions in older Dinale A. Platelet aggregation and coronary
persons: prevalence and correlates of heart disease risk factor variation in Australian
hyperlipidemia, 15-21 populations with different coronary heart disease
Colsher PL. Conceptual problems in identifying mortality, 495—508
risk factors for functional decline in the Wilson PWF. see Castelli WP
elderly: a commentary, 835-839 Wiman B. see Humphries SE
Wax Y. see Simchen E Wolf PA. see O’Leary DH
Weiss ST. see Schwartz J Wu K. see Chambless LE
Welin L, Eriksson H, Larsson B, Svardsudd K, Wu KK
Tibblin G, Wilhelmsem L. Triglycerides and Folsom AR, Heiss G, Davis CE, Conlan MG,
blood glucose are the major coronary risk factors Barnes R. Association of coagulation factors
in elderly Swedish men: the study of men born and inhibitors with carotid artery
in 1913, 113-119 atherosclerosis: early results of the
Wenger NK. see Manolio TA Atherosclerosis Risk in Communities (ARIC)
Wessler S. Estrogen-associated thromboembolism, Study, 471-480
439-443 see Folsom AR
Whelton PK, Hebert PR, Cutler J, Applegate Wynn PS. see Lowenfels AB
WB, Eberlein KA, Klag MJ, Keough ME,
Hamill S, Borhani NO, Hollis J, Oberman A. Xue S. see Sprafka JM
Baseline characteristics of participants in phase |
of the Trials of Hypertension Prevention, Yu SM, Nagey DA. Validity of self-reported
295-310 pregravid weight, 714-721
White AD, Hames CG, Tyroler HA. Serum
cholesterol and 20-year mortality in black and Zimetbaum P. see Frishman WH
Subject Index
A for myocardial infarction
Acquired immunodeficiency syndrome long-term treatment, 549-552
in pregnant women, 773—803 Antiplatelet agents. see also specific agent
Acute myocardial infarction. see Myocardial influence on coronary vascular disease
infarction development, 529-542
Adolescent pregnancy Antithrombin III
outcome, 565—575 levels
(editorial), 755-757 cardiovascular risk factors in middle-aged
Age. see also Geriatrics adults and, 481—494
coronary heart disease and carotid artery atherosclerosis associated with,
distribution of coagulation factors VII and 471-480
VIII and fibrinogen in adults over 65 years Arsenic
related to, 509-519 lung cancer and, 195-211
in hypertensives, cholesterol levels and, Aspirin
155-160 influence on coronary vascular disease
in men, 107-111 development, 529-542
mortality related to, cholesterol levels and, Asthma
93-99 symptoms
decline in stature related to caffeine effects on, 627—635
in women, 611-615 Atherosclerosis. see also Cardiovascular disease
Alcohol intake carotid
lung cancer development and cholesterol levels and, 147—153
in postmenopausal women, 587—595 coagulation factors and inhibitors associated
pregnancy estrogens in relation to, 241—247 with, 471-480
vehicular fatalities in relation to estrogen linkage to, 439-443
international trends in, 249-256 fibrinogen levels in, 457—466
(editorial), 339-341 lipoprotein (a) role in
Androgens mechanisms modulating, 413-417
endogenous structure related to, 407-412
central adiposity in men and, 675—682 plaque rupture
Angina pectoris onset of, triggering and hourly variation in,
cardiovascular risk factors in 393-405
relationship with hemostasis, 521-524 role of coagulation and fibrinolysis in, 427—438
Angiography
in coronary artery disease, 129-136, 137-145
Announcements B
Safeguarding America’s Health: A Clinical Basal cell carcinoma
Epidemiology Symposium. October 29-30, in women
1992, 771 diet in relation to, 231-239
Antibiotics Beer intake
salmonellosis development associated with, lung cancer development and, 587—595
683-696 Birth weight
Anticoagulants. see also specific agent influence of young maternal age and parity on,
influence on coronary vascular disease 565-575
development, 529-542 Blacks. see Race
© 1992 Elsevier Science Publishing Co., Inc. 1047-2797/92/$03.50
864 SUBJECT INDEX AEP Vol. 2, No. 6
November 1992: 863-871
Blood pressure. see also Hypertension weight loss effects on, in elderly, 35-41
glucose tolerance and distribution
cardiovascular disease risk related to, 647-656 in elderly, 15-21
reduction screening
life style and nutrition management effects in childhood
on, 295-310 (letters), 763-765, 766—767
Breast cancer Cigarette smoking. see Smoking
pregnancy estrogens and, 241-247 Circadian rhythm
risks variations in
hair dye use related, 577—586 in onset of arterial thrombosis, 393—405
lifetime body size changes related to, 597-609 Clinical epidemiology
Breast disease (commentary), 325-333
benign Clinical trials
hair dye use related, 577—586 in hypertension prevention, 295-310
Bronx Aging Study Coagulation
on serum lipids and lipoproteins in advanced cardiovascular disease and, 427—438
age, 43-50 analytes for diagnosis, 365-370
anticoagulant agents effects on, 529-542
C Coagulation factors. see also specific factor
Cadmium association with carotid artery atherosclerosis,
lung cancer risk and, 177-194, 195-211 471-480
(editorial), 335-337 cardiovascular risk related to
Cancer. see specific body area; specific type of ethnic differences in, 495—508
cancer in middle-aged adults, 481-494
mortality Coffee
selenium, retinol, retinol-binding proteins, effect on asthma symptoms, 627-635
uric acid blood and tissue levels and intake
(letter), 343-344 pregnancy estrogens in relation to, 241—247
Cardiovascular disease. see Atherosclerosis; Cohort study
Coronary heart disease on alcohol and beer consumption effects on lung
Carotid sonography cancer development in postmenopausal
in extracranial atherosclerosis, 147-153 women, 587—595
Case-control study on coronary heart disease risk factors in elderly,
on hair dye use in relation to breast cancer, 273-282
577-586 Combat disorders
on lung cancer risk among cadmium-exposed in Vietnam War veterans
workers, 195-211 studies of, methodological difficulties in,
Chemical spills 841-853
hydrofluoric acid Community health
health sequelae of, 213-230 impact of hydrofluoric acid exposure on,
Children 213-230
cholesterol screening Confidence limits
(letters), 763—765, 766—767 likelihood-based
Cholesterol. see also Lipids calculation, for small-study regression results
carotid atherosclerosis and (letters), 767-770
in elderly, 147—153 Coronary artery
coronary heart disease and, 129-136 patency
in adult and older men, 29-34, 59-67, thrombolytic therapy effects on, 543-548
107-111, 113-119 Coronary artery disease. See Coronary heart
age and sex differences in, 69—72, 77-83, disease
121-128, 137-145, 161-176 Coronary heart disease. See also Atherosclerosis;
in female and older hypertensives, 155-160 Ischemic heart disease; Myocardial infarction
mortality rates, race, sex and age differences cholesterol levels and, 129-136
in, 23-28, 51-57, 85-91, 93-99 in adult and older men, 59-67, 107-111
AEP Vol. 2, No. 6 SUBJECT INDEX 865
November 1992: 863-871
age and sex differences in, 77-83, 121-128, Diet. see also Nutrition
137-145, 171-176 basal cell carcinoma in women in relation to,
in female and older hypertensives, 155—160 231-239
weight loss effects on, in elderly, 35—41 hemostasis and thrombosis effects
diabetes and coronary heart disease and, 387-391
in Mexican Americans, 101—106 lipid lowering
in elderly, 5-14 influence on hemostatic risk variables in
hemostatic factors in, 467-469, 481-494 cardiovascular disease, 525—527
diet and smoking effects on, 387-391 relationship to disease
intraindividual variability in, 723—733 (letter), 343
25-hydroxyvitamin D; plasma levels related to, Dioxins
697-703 exposure to
lipoprotein (a) structure and, 407—412 in Vietnam War veterans, health status
mortality effects of, studies of, methodological
cholesterol levels and, age, sex and race difficulties in, 841-853
differences in, 51-57, 69—76, 93-99 Disease
onset of nutrient status and diet in relationship to
triggering and hourly variation in, 393-405 (letter), 343
overview and research opportunities, 553-556 prevention
risk factors in the elderly, 813-822
in elderly, compared to middle age, 273-282
ethnic differences in, 495—508
fibrinogen as, 457—466 E
glucose intolerance and, 647-656 Education. see Teaching
lipids and lipoproteins and, age and sex Elderly. see Geriatrics
differences in, 23-28, 29-34 Epidemiology
race differences in, 637-645 clinical
triglycerides and blood glucose levels and, in (commentary), 325-333
elderly men, 113-119 ethics related to
Coronary thrombosis (editorial), 761
onset of interpretation of linear regression models that
triggering and hourly variation in, 393—405 include transformations or interaction terms,
Corrections 735-744
(letter), 344-345 likelihood-ratio testing
as diagnostic model for small-sample
regression analysis, 311-316
Estrogen
D post-menopausal therapy
Demographics non-insulin-dependent diabetes mellitus
prevalence, incidence, and management of development and, 665-673
coronary heart disease in elderly, 5—14 (editorial), 759-760
Diabetes pregnancy levels
cardiovascular disease risk in, 647—656 in relation to coffee and alcohol intake,
in Mexican Americans, 101—106 241-247
insulin-dependent salmonellosis development associated with,
younger-onset, glycemia changes in four-year 683-696
period in, 283-294 thromboembolism and, 439-443
non-insulin-dependent Ethics
postmenopausal estrogen therapy and, guidelines for epidemiologists
665-673 (editorial), 761
(editorial), 759-760 Ethnicity. see also Race
weight fluctuation association with, 657—664 risk factors for coronary heart disease related to,
salmonellosis development associated with, 495-508
638-696 Exercise. see Physical activity
866 SUBJECT INDEX AEP Vol. 2, No. 6
November 1992: 863-871
F Flourides
Factor VII hip fracture and
cardiovascular risk factors related to in elderly, 617—626
diet and smoking effects on, 387-391 Fluoridation
distribution in adults over 65 year and, of water
509-519 hip fracture in elderly and, 617-626
early carotid artery atherosclerosis and, Functional ability
471-480 in elderly
in middle-aged adults, 491—494 decline, risk factors for, identification of,
plasma levels conceptual problems in, 835-839
genetic variations in, 371—385 maintenance of, 823—834
Factor VIII
G
cardiovascular risk factors related to
Gastrointestinal disease
in middle-aged adults, 481—494
intraindividual variability in, 723-733 salmonellosis
Factory determinants of, 683-696
excess disease in Geriatrics. see also Age
blood lipid distributions
regression analysis, likelihood-ratio testing as
diagnostic method in, 311-316 hyperlipidemia and, 15-21
Family correlations coronary heart disease, cholesterol levels and,
sibship 5-14, 29-34, 43-50, 161-176
in pulmonary function data, race differences distribution of coagulation factors VII and
in, 317-322 VIII and fibrinogen and, 509-519
Fat in men, 59—67
dietary mortality rates, 51-57, 85-91
effects on hemostatic factors related to risk factors in, compared to middle aged,
273-282
coronary heart disease, 387—391
Females. see Women sex differences in, 69-76, 77—83
Femoral neck triglycerides and blood glucose levels and, in
fracture men, 113-119
weight loss effects on, 35—41
in elderly, water fluoridation effects on,
617-626 functional ability
Fibrin decline, risk factors for, identification of,
ischemic heart disease and, 353—364 conceptual problems in, 835-839
Fibrinogen maintenance of, 823—834
coronary heart disease and, 457-466 infection and immune response and, 813-822
diet and smoking effects on, 387—391 Glucose
distribution in adults over 65 year and, coronary heart disease and
509-519 in elderly men, 113-119
early atherosclerosis related to, 471-480 impaired tolerance related to, 647—656
relationship with angina pectoris, Glycemia
521-524 in younger-onset insulin-dependent diabetes
intraindividual variability in, 723-733 mellitus
plasma levels changes in four-year interval, 283-294
Glycoprotein IIb/IIIa
genetic variations in, 371—385
antiplatelet agents against
Fibrinolysis. see also Thrombolysis
deficient influence on coronary vascular disease
development, 529-542
role in development of atherosclerosis,
427-438 Gonadal tumors
genetic factors determining, 371—385 pregnancy estrogens and, 241—247
influence of lipid-lowering diets on, 525-527
lipoprotein (a) and, 407-412 H
plasminogen activators assembly on surface of Hair dyes
relation to breast cancer development, 577—586
human endothelial cells, 419-426